3L Bio (CEO Kyeong-ro Lee) announced that it will participate in the 23th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 26’, which will be held at COEX, Seoul from Thursday, March 38 to Sunday, March 2023.
Founded in 2015, 13485L Bio is a company that manufactures and sells threads and needles using absorbable sutures of various materials. In addition, the company explains that it holds various related patents, including devices and methods for automatically assembling implantation equipment, and has obtained CE, ISO XNUMX, GMPL, and KFDA approvals for its products and production facilities, ensuring high safety and quality.
In this exhibition, XNUMXL Bio presents a variety of its selling products. In addition to polydioxa (PDO) products, which have been commonly used in surgery for a long time, products based on polyelactic (PCL) and polyelcaprolactone (PLCL) sutures, which are also threads that dissolve in the body, were developed and added to the lineup.
The ‘Mold’ product, which is considered a representative product, is characterized by further improving the quality by using proprietary equipment designed and manufactured by 500L Bio CEO Kyung-ro Lee, who has a doctorate in mechanical engineering and is currently a professor. TWIN MOLD, which is also being introduced, also has the distinction of having a longer length compared to other products and being able to manufacture over XNUMXmm.
A XNUMXL Bio official said, “Our products were developed in line with customer demand for newer and improved products, and we have already been able to confirm the response of customers who are satisfied with the quality.” He added, “We have already been able to confirm the response of customers who are satisfied with the quality.” He explained, “We have customers and are achieving export results, and we have also secured a wide range of suppliers through OEM.”
He continued, “We plan to handle a wider variety of products in the future. “Previously, we only had meltable threads in our portfolio, but considering the ease of treatment in the beauty industry, we plan to add fillers, botox, and functional cosmetics to our products,” he said. “In addition, through this KIMES, we will lay the foundation for entering new markets and regions.” “It is,” he added.
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.